Cargando…

Correction: Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma

Detalles Bibliográficos
Autores principales:	Lai, Jinzhi, Xu, Tianwen, Yang, Hainan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059357/ https://www.ncbi.nlm.nih.gov/pubmed/35501773 http://dx.doi.org/10.1186/s12885-022-09517-0

Ejemplares similares

Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma
por: Lai, Jinzhi, et al.
Publicado: (2022)

Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma
por: Lai, Jinzhi, et al.
Publicado: (2021)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival
por: Morales, Leah, et al.
Publicado: (2023)

A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
por: Jin, Xinmin, et al.
Publicado: (2022)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Independent prognostic importance of microvessel density in endometrial carcinoma
Publicado: (1998)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
por: Ling, Feng, et al.
Publicado: (2023)

Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Publicado: (2022)

Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022)

Correction: A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma
por: Yan, Qian, et al.
Publicado: (2023)

Author Correction: A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy
por: Fu, Qiang, et al.
Publicado: (2018)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

Identification of autophagy‐related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA)
por: Cao, Rui, et al.
Publicado: (2021)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Gene signature to predict prognostic survival of hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2022)

Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness
por: Pienkowska, Malgorzata, et al.
Publicado: (2019)

SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers
por: Mei, Jie, et al.
Publicado: (2023)

Correction: PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer
por: Wishart, Gordon C, et al.
Publicado: (2010)

Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
Publicado: (2021)

Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma
por: Shi, Rongfeng, et al.
Publicado: (2022)

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
por: Buqué, Aitziber, et al.
Publicado: (2020)

Identification of the Ferroptosis-Associated Gene Signature to Predict the Prognostic Status of Endometrial Carcinoma Patients
por: Qin, Jinlong, et al.
Publicado: (2021)

Correction: Hong Kong Hospital Authority resource efficiency evaluation: Via a novel DEA-Malmquist model and Tobit regression model
por: Guo, Hainan, et al.
Publicado: (2018)

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
por: Zhou, Meng, et al.
Publicado: (2018)

Author Correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

Correction to: Aspinall S, et al. Human Vaccines and Immunotherapeutics Volume 8, Issue 8; pp.1109–18
por: Aspinall, Sanet, et al.
Publicado: (2013)

Correction to: A six-gene expression signature related to angiolymphatic invasion is associated with poor survival in laryngeal squamous cell carcinoma
por: Metzger, Karl, et al.
Publicado: (2021)

Correction: Cells expressing PAX8 are the main source of homeostatic regeneration of adult mouse endometrial epithelium and give rise to serous endometrial carcinoma
por: Fu, Dah-Jiun, et al.
Publicado: (2023)

Correction to: Potential association of the prognostic index and survival in patients with p16-positive oropharyngeal squamous cell carcinoma
por: Brkic, Faris F., et al.
Publicado: (2021)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

Correction: Comparison of the cox regression to machine learning in predicting the survival of anaplastic thyroid carcinoma
por: Xu, Lizhen, et al.
Publicado: (2023)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n2p0f3ra86n5v6hioq1fdeofpo